Amylin Pharmaceuticals (AMLN) Sees Late Day Pressure
Tweet
Share
E-mailGet Alerts AMLN Hot Sheet
Join SI Premium – FREE
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) sees downside action late in the session. Share are down 3%.
In March the company rejected a $22 share bid from Brisol-Myers (NYSE: BMY), although others are said to come with higher bids.
Today's action suggest some may be dropping out of the bidding, although we haven't seen anything official.
In March the company rejected a $22 share bid from Brisol-Myers (NYSE: BMY), although others are said to come with higher bids.
Today's action suggest some may be dropping out of the bidding, although we haven't seen anything official.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FOMC minutes from July 28-29th meeting
- US and Canada reach tentative deal to halve steel and aluminum tariffs - Bloomberg
- U.S. Treasury doubles buyback operation size for long-dated bonds
Create E-mail Alert Related Categories
Rumors, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
